This job has expired

You will need to login before you can apply for a job.

Research Associate III, Arcus Production

Employer
Precision BioSciences, Inc.
Location
Durham, NC
Start date
Sep 20, 2022

View more

You need to sign in or create an account to save a job.

Job Details

Summary

 

Precision BioSciences is seeking a Research Associate III to help produce our ARCUS nuclease.  The position will help maintain stock solutions and may need to produce electrocompetent cells to facilitate ARCUS production.  The candidate will have excellent molecular biology skills and some familiarity with directed evolution and DNA library generation.  The candidate must be extremely detail oriented, have excellent communication skills, and enjoy working in a collaborative environment. 

 

**Please note, Precision BioSciences mandates COVID-19 vaccination of all employees. Accommodations may be made in accordance with applicable law.

 

Essential Duties and Responsibilities

Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of this position.  This list contains the major duties and requirements of the job and is not all-inclusive. Incumbent(s) may be expected to perform role-related duties other than those contained in this document.

 

  • Perform library selections to isolate functional ARCUS nucleases
  • Produce selection libraries
  • Maintain an accurate, detailed, up to date notebook
  • Generate electrocompetent bacteria, as necessary
  • Generate DNA templates through PCR or DNA minipreps
  • Analyze and purify DNA on Agarose gel electrophoresis
  • Restriction digest analysis
  • Perform large and small scale plasmid purification
  • Electroporate bacteria with plasmid DNA
  • Titer electroporated bacteria on selective media
  • Maintain stocks of necessary reagents (IPTG, antibiotics, sucrose)
  • Cloning

 

Qualifications

The requirements listed below are representative of the knowledge, skill, and/or ability required to perform this job successfully.

 

Required:

  • Bachelor’s degree in Biology or Molecular Biology and 5+ years of experience, or equivalent combination of education and experience
  • Strong background in molecular biology with wet lab experience
  • Experience with bacterial positive and negative selections

 

Preferred:

•             Experience working with DNA-binding proteins

•             Experience in directed evolution experiments

•             Background in genome editing and/ or homologous recombination

•             Exposure to cell culture work to facilitate collaborations

•             Strong communication skills, including written and verbal reporting to supervisor, team, company, and at conferences.

 

Travel Requirements

· Minimal travel is anticipated for this position.

 

Location

· This is a primarily lab-based position associated with the main headquarters in Durham, NC.

 

Precision BioSciences, Inc. (Nasdaq: DTIL), is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. This isn’t just a statement supporting the products that we’re developing – it’s a statement that speaks to our collective desire to do our part in improving the lives of those around us. ARCUS is a highly specific and versatile genome editing platform designed with therapeutic safety, delivery, and control in mind. Using ARCUS, Precision is developing allogeneic CAR T and in vivo gene correction therapies for cancer and genetic diseases. Our team includes pioneers in genome editing, leaders in business, and a full staff of talented and committed people who are excited to be a part of medical and scientific breakthroughs.  For additional information, please visit www. precisionbiosciences.com

 

Precision BioSciences actively fosters an inclusive environment to ensure we attract and retain the best talent; we value diversity of life experiences and perspectives; and we encourage innovation in pursuit of our mission. We provide equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable federal, state and local laws. Precision BioSciences complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.

 

 

Company

Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing and ex vivo allogeneic CAR T therapies with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly sophisticated edits for gene insertion and/or gene repair. Precision’s in vivo gene editing pipeline consists of wholly-owned preclinical candidates for primary hyperoxaluria type 1 (PBGENE-PH1), familial hypercholesteremia (PBGENE-PCSK9) and chronic hepatitis B (PBGENE-HBV). It has also partnered with Lilly to develop candidates for Duchenne muscular dystrophy and two other programs targeting the liver and CNS. Precision’s allogeneic CAR T pipeline consists of multiple investigational candidates in early-stage clinical trials, including its first and second generation CD19 targeting candidates PBCAR0191 and PBCAR19B for relapsed and/or refractory (R/R) non-Hodgkin and B-cell lymphoma patients. Precision has also prioritized development of PBCAR269A, its BCMA targeted candidate in combination with a gamma secretase inhibitor for R/R patients with multiple myeloma. Precision BioSciences and its in-house manufacturing facility for AAV, mRNA, and CAR T cells is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com

Stock Symbol: DTIL

Stock Exchange: NASDAQ

Find Us
Website
Phone
919-314-5512
Location
302 East Pettigrew Street
Durham
North Carolina
27701
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert